A novel multi-target RNAi adenovirus inhibits hepatoma cell proliferation, migration, and induction of angiogenesis
Authors:
Open Access
- 21 May 2016
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (36) , 57705-57713
Abstract
// <![CDATA[ $('.header-date').hide();$('#titleAuthors').hide();$('#abstractHeader').hide(); // ]]> Mei Huang1, *, Guangyao Li1, *, Tingting Pan1, Ya Cheng1, Weihua Ren1, Weidong Jia1, 2, Jinliang Ma1, 2, Geliang Xu1, 2 1Anhui Province Key Laboratory of Hepatopancreatobiliary Surgery, Hefei 230001, China 2Department of Hepatic Surgery, Affiliated Provincial Hospital of Anhui Medical University, Hefei 230001, China *These authors have contributed equally to this work Correspondence to: Geliang Xu, e-mail: xugeliang2015@163.com Keywords: hepatocellular carcinoma, adenovirus, VEGFR2, CCR1, EpCAM Received: October 27, 2015 Accepted: May 04, 2016 Published: May 21, 2016Keywords
This publication has 19 references indexed in Scilit:
- MiR-449a suppresses the epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma by multiple targetsBMC Cancer, 2015
- In vivo study of the effect of combining endostatin gene therapy with 32P-colloid on hepatocarcinoma and its functioning mechanism.2015
- Multiple Molecular Pathways in Melanomagenesis: Characterization of Therapeutic TargetsFrontiers in Oncology, 2015
- Hepatocellular carcinoma: Where there is unmet needMolecular Oncology, 2015
- Global cancer statistics, 2012CA: A Cancer Journal for Clinicians, 2015
- The Diagnosis and Treatment of Hepatocellular CarcinomaDeutsches Ärzteblatt international, 2014
- Tumor Metastasis: Molecular Insights and Evolving ParadigmsCell, 2011
- Downregulation of CCR1 inhibits human hepatocellular carcinoma cell invasionBiochemical and Biophysical Research Communications, 2007
- Expression of epithelial cellular adhesion molecule (Ep-CAM) in chronic (necro-)inflammatory liver diseases and hepatocellular carcinomaHepatology Research, 2006
- Essential contribution of a chemokine, CCL3, and its receptor, CCR1, to hepatocellular carcinoma progressionInternational Journal of Cancer, 2005